From variant to disorder
A harmful variant causes disease by changing what a protein does — or how much of it the body has. The main patterns:
- Loss of function — the protein is missing, shortened, or broken, so its job does not get done. Nonsense, frameshift, and large-deletion variants often work this way.
- Gain of function — the protein is still made, but it now does something new or excessive — sometimes harmful in a way that losing it would not be.
- Dominant-negative — a faulty copy of the protein actively interferes with the good copy, so the damage is worse than simply having less.
Dosage and haploinsufficiency
For many genes — especially genes the developing brain depends on — *how much* working protein you have matters a great deal. These genes are dosage-sensitive.
Haploinsufficiency is a key idea here: you normally have two copies of each gene, and for a dosage-sensitive gene, one working copy is not enough to do the full job. Lose or break one copy and you fall below the amount the body needs. This is why a single loss-of-function variant can cause a serious condition even when the second copy is perfectly fine.
Why the same gene can cause different conditions
Two children can have variants in the same gene and look quite different. Several reasons:
- Where the variant falls in the gene can change the outcome — one region of a protein may control one job, another region a different job.
- What kind of variant it is matters — a complete loss-of-function change can be more severe than a milder missense change.
- The rest of a person's genome and biology — their genetic background — modifies how a variant plays out.
The link between the exact genetic change (the genotype) and the observable traits (the phenotype) is called the genotype–phenotype relationship. For rare genes, this map is often only partly drawn, which is why honest sources describe a *spectrum* rather than a single fixed outcome.
Why ultra-rare conditions are hard to study
When only a few hundred people in the world share a diagnosis, ordinary medical research gets very hard:
- Small numbers make it difficult to tell a real pattern from chance. A finding in 4 children is not the same kind of evidence as a finding in 4,000.
- Wide variation between patients means averages can hide as much as they reveal.
- Few specialists have seen many cases, so shared knowledge accumulates slowly.
- Natural history — how a condition typically changes over years — is often not yet well documented, which makes it hard to know whether a treatment is helping.
None of this means progress is impossible. It means evidence must be read carefully, and that strong-sounding claims from very small studies deserve healthy caution. Focena's whole job is to grade *how solid* each piece of evidence actually is.
> Research evidence about these mechanisms is often early and uncertain. Confirmed findings are labeled as such; treat the rest as working hypotheses, not settled facts.